William H Jones, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1949 Hospital Dr, Martinsville, IN 46151 Phone: 765-342-7156 Fax: 765-349-9935 |
Stephen L Hardin, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2209 John R Wooden Dr, Martinsville, IN 46151 Phone: 765-342-8383 Fax: 765-349-8413 |
Joshua J Eskonen, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1949 Hospital Dr, Martinsville, IN 46151 Phone: 765-349-6779 Fax: 765-349-8413 |
Dr. Ryan R. Lacy, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 49 Bills Blvd, Martinsville, IN 46151 Phone: 765-349-3627 Fax: 765-349-3630 |
Thomas F Lahr, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 1609 Burton Ln, Martinsville, IN 46151 Phone: 765-315-0126 Fax: 765-315-0151 |
Michael E. Teague, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1949 Hospital Dr, Martinsville, IN 46151 Phone: 765-342-8383 Fax: 765-349-8413 |
Dr. Danielle Cadle, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2209 John R Wooden Dr, Martinsville, IN 46151 Phone: 765-342-8383 |
News Archive
Actelion Pharmaceuticals US, Inc. today announced the commercial availability of Epoprostenol for Injection, an improved formulation of epoprostenol that is stable at room temperature, for the treatment of primary pulmonary hypertension and pulmonary hypertension associated with scleroderma spectrum of disease in NYHA Class III and Class IV patients.
Rockwell Medical, a fully-integrated biopharmaceutical company offering innovative products and services targeting end-stage renal disease (ESRD), chronic kidney disease (CKD), and iron-deficiency anemia, announced today the design of its Phase III development program for Soluble Ferric Pyrophosphate (SFP) as a continuous iron replacement therapeutic.
Researchers from Mount Sinai School of Medicine and two other academic institutions have received federal funding to systematically assemble functional human kidney tissue from tissue modeled on a computer. If successful, the research-which ties together several emerging technologies including virtual tissue modeling and nanofabrication-could lead to a more predictable way for researchers to engineer tissue outside the body and, consequently, to screen for new drugs.
An Indiana University and Regenstrief Institute study is the first to report significantly decreased incidence rates over two decades for Alzheimer's disease and other dementias in African-Americans. The study is also the first to show that the incidence rate of these conditions in Africans was unchanged over the same period.
› Verified 7 days ago